Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1994 Jan;71(1):30–33. doi: 10.1136/hrt.71.1.30

Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine.

H Ikram 1, C J Low 1, T M Shirlaw 1, S G Foy 1, I G Crozier 1, A M Richards 1, N S Khurmi 1, R J Horsburgh 1
PMCID: PMC483605  PMID: 8297690

Abstract

OBJECTIVES--To determine the anti-ischaemic effects of a new angiotensin converting enzyme inhibitor, benazepril, compared with nifedipine, alone and in combination, in chronic stable angina caused by coronary artery disease. DESIGN--Placebo controlled, double blind, latin square design. SETTING--Regional cardiology service for a mixed urban and rural population. SUBJECTS--40 patients with stable exertional angina producing at least 1 mm ST segment depression on exercise test with the Bruce protocol. 34 patients completed all four phases of the trial. INTERVENTIONS--Each patient was treated with placebo, benazepril (10 mg twice daily), nifedipine retard (20 mg twice daily), and a combination of benazepril and nifedipine in the same doses, in random order for periods of two weeks. MAIN OUTCOME MEASURES AND RESULTS--Total duration of exercise was not increased by any treatment. Exercise time to the development of 1 mm ST segment depression was not significantly changed with benazepril alone or in combination with nifedipine but was increased with nifedipine from 4.18 (1.8) min to 4.99 (1.6) min (95% confidence interval (95% CI) 0.28 to 1.34; p < 0.05). There was a significant relation between increase in duration of exercise and resting renin concentration (r = 0.498; p < 0.01). Myocardial ischaemia during daily activity, as assessed by ambulatory electrocardiographic monitoring, was reduced by benazepril and by the benazepril and nifedipine combination. This was significant for total ischaemic burden (451(628) min v 231(408) min; 95% CI -398 to -41 min; p < 0.05) and maximal depth of ST segment depression (-2.47(1.2) mm v -2.16 mm; 95% CI 0.04 to 0.57; p < 0.05) for the combination and for maximal ST segment depth for benazepril monotherapy (-2.47 (1.2) mm v -1.96(1.2) mm; 95% CI 0.18 to 0.91; p < 0.05). Benazepril significantly altered the circadian rhythm of cardiac ischaemia, abolishing the peak ischaemic periods at 0700 to 1200 and 1700 to 2300 (p < 0.05). CONCLUSIONS--Benazepril, an angiotensin converting enzyme inhibitor, had a modest anti-ischaemic effect in effort angina, but this effect was not as pronounced as with nifedipine. The anti-ischaemic action was more noticeable in asymptomatic ischaemia during daily activity, whereas nifedipine had little effect on this aspect of myocardial ischaemia. The combination of benazepril and nifedipine reduced ischaemia of daily activity.

Full text

PDF
30

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams J. Is there a role for angiotensin-converting enzyme inhibitors in the treatment of chronic myocardial ischemia? J Am Coll Cardiol. 1990 Oct;16(4):957–958. doi: 10.1016/s0735-1097(10)80348-1. [DOI] [PubMed] [Google Scholar]
  2. Brandt P. W., Partridge J. B., Wattie W. J. Coronary arteriography; method of presentation of the arteriogram report and a scoring system. Clin Radiol. 1977 Jul;28(4):361–365. doi: 10.1016/s0009-9260(77)80140-2. [DOI] [PubMed] [Google Scholar]
  3. Bruce R. A., Hornsten T. R. Exercise stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis. 1969 Mar;11(5):371–390. doi: 10.1016/0033-0620(69)90027-9. [DOI] [PubMed] [Google Scholar]
  4. Cleland J. G., Henderson E., McLenachan J., Findlay I. N., Dargie H. J. Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. J Am Coll Cardiol. 1991 Mar 1;17(3):733–739. doi: 10.1016/s0735-1097(10)80192-5. [DOI] [PubMed] [Google Scholar]
  5. Clough D. P., Collis M. G., Conway J., Hatton R., Keddie J. R. Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system. Am J Cardiol. 1982 Apr 21;49(6):1410–1414. doi: 10.1016/0002-9149(82)90352-6. [DOI] [PubMed] [Google Scholar]
  6. Cocco G., Strozzi C., Chu D., Amrein R., Castagnoli E. Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. Eur J Cardiol. 1979 Jul;10(1):59–69. [PubMed] [Google Scholar]
  7. Daly P., Mettauer B., Rouleau J. L., Cousineau D., Burgess J. H. Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect. Circulation. 1985 Feb;71(2):317–325. doi: 10.1161/01.cir.71.2.317. [DOI] [PubMed] [Google Scholar]
  8. Dunn P. J., Espiner E. A. Outpatient screening tests for primary aldosteronism. Aust N Z J Med. 1976 Apr;6(2):131–135. doi: 10.1111/j.1445-5994.1976.tb03306.x. [DOI] [PubMed] [Google Scholar]
  9. Ertl G. Coronary vasoconstriction in experimental myocardial ischemia. J Cardiovasc Pharmacol. 1987;9 (Suppl 2):S9–17. doi: 10.1097/00005344-198700002-00004. [DOI] [PubMed] [Google Scholar]
  10. Greene D. G., Carlisle R., Grant C., Bunnell I. L. Estimation of left ventricular volume by one-plane cineangiography. Circulation. 1967 Jan;35(1):61–69. doi: 10.1161/01.cir.35.1.61. [DOI] [PubMed] [Google Scholar]
  11. Katz R. J., Levy W. S., Buff L., Wasserman A. G. Prevention of nitrate tolerance with angiotension converting enzyme inhibitors. Circulation. 1991 Apr;83(4):1271–1277. doi: 10.1161/01.cir.83.4.1271. [DOI] [PubMed] [Google Scholar]
  12. Klein W. W., Khurmi N. S., Eber B., Dusleag J. Effects of benazepril and metoprolol OROS alone and in combination on myocardial ischemia in patients with chronic stable angina. J Am Coll Cardiol. 1990 Oct;16(4):948–956. doi: 10.1016/s0735-1097(10)80347-x. [DOI] [PubMed] [Google Scholar]
  13. Lambertz H., Grenner H., Zander M. Bewegungsanalyse des Carpentier-Ringes in Trikuspidalposition: Eine echokardiographische und hämodynamische Studie. Z Kardiol. 1987 Jan;76(1):30–37. [PubMed] [Google Scholar]
  14. Liang C. S., Gavras H., Hood W. B., Jr Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics. J Clin Invest. 1978 Apr;61(4):874–883. doi: 10.1172/JCI109013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Linz W., Schölkens B. A., Han Y. F. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. J Cardiovasc Pharmacol. 1986;8 (Suppl 10):S91–S99. doi: 10.1097/00005344-198600101-00017. [DOI] [PubMed] [Google Scholar]
  16. Moravec C. S., Schluchter M. D., Paranandi L., Czerska B., Stewart R. W., Rosenkranz E., Bond M. Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation. 1990 Dec;82(6):1973–1984. doi: 10.1161/01.cir.82.6.1973. [DOI] [PubMed] [Google Scholar]
  17. Mulcahy D., Keegan J., Cunningham D., Quyyumi A., Crean P., Park A., Wright C., Fox K. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet. 1988 Oct 1;2(8614):755–759. doi: 10.1016/s0140-6736(88)92414-2. [DOI] [PubMed] [Google Scholar]
  18. Muller J. E., Ludmer P. L., Willich S. N., Tofler G. H., Aylmer G., Klangos I., Stone P. H. Circadian variation in the frequency of sudden cardiac death. Circulation. 1987 Jan;75(1):131–138. doi: 10.1161/01.cir.75.1.131. [DOI] [PubMed] [Google Scholar]
  19. Muller J. E., Stone P. H., Turi Z. G., Rutherford J. D., Czeisler C. A., Parker C., Poole W. K., Passamani E., Roberts R., Robertson T. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985 Nov 21;313(21):1315–1322. doi: 10.1056/NEJM198511213132103. [DOI] [PubMed] [Google Scholar]
  20. Muller J. E., Tofler G. H., Stone P. H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989 Apr;79(4):733–743. doi: 10.1161/01.cir.79.4.733. [DOI] [PubMed] [Google Scholar]
  21. Nademanee K., Intarachot V., Josephson M. A., Singh B. N. Circadian variation in occurrence of transient overt and silent myocardial ischemia in chronic stable angina and comparison with Prinzmetal angina in men. Am J Cardiol. 1987 Sep 1;60(7):494–498. doi: 10.1016/0002-9149(87)90292-x. [DOI] [PubMed] [Google Scholar]
  22. Shell W. E., Dobson D. Dissociation of exercise tolerance and total myocardial ischemic burden in chronic stable angina pectoris. Am J Cardiol. 1990 Jul 1;66(1):42–48. doi: 10.1016/0002-9149(90)90733-h. [DOI] [PubMed] [Google Scholar]
  23. Simon J., Gibbs R., Crean P. A., Mockus L., Wright C., Sutton G. C., Fox K. M. The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina. Br Heart J. 1989 Aug;62(2):112–117. doi: 10.1136/hrt.62.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stone P. H., Gibson R. S., Glasser S. P., DeWood M. A., Parker J. D., Kawanishi D. T., Crawford M. H., Messineo F. C., Shook T. L., Raby K. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group. Circulation. 1990 Dec;82(6):1962–1972. doi: 10.1161/01.cir.82.6.1962. [DOI] [PubMed] [Google Scholar]
  25. Strozzi C., Cocco G., Portaluppi F., Urso L., Alfiero R., Tasini M. T., Montanari L., Al Yassini K., Rizzo A. Effects of captopril on the physical work capacity of normotensive patients with stable-effort angina pectoris. Cardiology. 1987;74(3):226–228. doi: 10.1159/000174201. [DOI] [PubMed] [Google Scholar]
  26. Strozzi C., Portaluppi F., Cocco G., Urso L. Ergometric evaluation of the effects of enalapril maleate in normotensive patients with stable angina. Clin Cardiol. 1988 Apr;11(4):246–249. doi: 10.1002/clc.4960110409. [DOI] [PubMed] [Google Scholar]
  27. Tarazi R. C., Zanchetti A. Prospectives for angiotensin converting enzyme inhibition in heart diseases. J Hypertens Suppl. 1985 Nov;3(2):S99–103. [PubMed] [Google Scholar]
  28. Xiang J. Z., Schölkens B. A., Ganten D., Unger T. Effects of sympathetic nerve stimulation are attenuated by the converting enzyme inhibitor Hoe 498 in isolated rabbit hearts. Clin Exp Hypertens A. 1984;6(10-11):1853–1857. doi: 10.3109/10641968409046091. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES